On March 23, 2024, President Biden signed into law the second of two minibus spending packages for fiscal year 2024 (FY 2024), which included the Labor-HHS bill. The House passed the measure on March 22, 2024, and the Senate passed it on March 23, 2024. The final Labor-HHS appropriations bill section totals $222.2 billion in base discretionary funding and provides $116.8 billion in funding for HHS. The bill includes $9.2 billion for CDC, an increase of $4.5 million over FY 2023. It also includes $681,933,000 for the Section 317 Immunization Program, which is level funded with FY 2023.

 

The conference bill includes the following legislative text relevant to the 317 Program:

 

IMMUNIZATION AND RESPIRATORY DISEASES

 

The agreement provides $9,222,090,000 in total program level funding for the Centers for Disease Control and Prevention (CDC), which includes $7,937,588,000 in budget authority and $1,186,200,000 in transfers from the Prevention and Public Health (PPH) Fund.

​

Within the total provided for the National Center for Immunization and Respiratory Diseases, the agreement includes the following amounts:

​

Budget Activity

Section 317 Immunization Program – $681,933,000

Acute Flaccid Myelitis – $6,000,000

Influenza Planning and Response – $231,358,000

​

Immunization Program. – The agreement directs CDC to support the existing immunization infrastructure, including the implementation of strategies for hard-to-reach populations.

 

The text of the FY 2024 Labor-HHS bill can be found here, and the Labor-HHS report can be found here.

​